Katherine Stueland

Chief Executive Officer

Katherine Stueland (Chief Executive Officer) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in GeneDx Holdings Corp. (WGS). The largest single filing was $3.0M of WGS (46,933 sh across 5 lots, as filed), executed Mar 26.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 14 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$12.3M

shares × price, as filed

Last traded

Sep 16

Filed Sep 18

Median ADV $82.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $37.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 14 filings

Sector per market data · by filing · past 12 months

Most traded names

WGS

GeneDx Holdings Corp. WGS · 0 buys · 33 sells 33 filings

Recent filings

WGSSALE GeneDx Holdings Corp. View filing → $1.0M
10,353 sh across 4 lots
Exec Sep 16
Filed Sep 18 · 4:43 PM ET WGSSALE GeneDx Holdings Corp. View filing → $311K
3,692 sh × $84.22
Exec Sep 9
Filed Sep 11 · 4:13 PM ET WGSSALE GeneDx Holdings Corp. View filing → $638K
10,501 sh across 3 lots
Exec Jun 16
Filed Jun 18 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $196K
3,639 sh × $53.77
Exec Jun 9
Filed Jun 11 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $140K
2,154 sh × $65.20
Exec Apr 29
Filed May 1 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $3.0M
46,933 sh across 5 lots
Exec Mar 26
Filed Mar 30 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $1.3M
16,407 sh across 2 lots
Exec Mar 16
Filed Mar 17 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $319K
3,678 sh × $86.75
Exec Mar 9
Filed Mar 11 · 5:30 PM ET More filings →